High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer

Japanese Journal of Clinical Oncology

Volumn 31, Issue 8, 2001, Pages 388-394

  Ota, Shunichiro ^a   Sugiyama, Toru ^a   Komai, Kan ^a   Hirai, Nobuyuki ^a   Kumagai, Seisuke ^a   Ushijima, Kimio ^a   Nishida, Takashi ^a   Kamura, Toshiharu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; D dimer; Fibrinolysis; Hypercoagulability; Postoperative survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; D DIMER; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL DISEASE; ENTERITIS; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NONBIOLOGICAL MODEL; PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

COLECTOMY; COLONIC NEOPLASMS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; SURVIVAL RATE;

EID: 0034792951     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid
2. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon
3. Evaluating prethrombotic state in lung cancer using molecular markers
4. Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer
5. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD) and von Willebrand factor (vWF) in patients with operable cervical cancer: Influence of surgical-pathological stage, tumor size, histologic type and lymph node status
6. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease
7. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients
8. Haemostatic abnormalities in lung cancer: Prognostic implications
9. Blood coagulation and thrombosis in patients with ovarian malignancy
10. Prognostic significance of plasma D-dimer levels in patients with lung cancer
11. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status
12. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC)
13. D-dimer: A useful marker of disease stage in surgery for colorectal cancer
14. Plasma D-dimer level in patients with colorectal cancer: Its role as a tumor marker
15. Plasma D-dimer measurement as a marker of gynecological tumors: Comparison with CA 125
16. D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy
17. Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer
18. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor
19. Systemic thrombin generation in cancer patients is correlated with extrinsic pathway activation
20. Factor X-activating activity in normal and malignant colorectal tissue
21. Non-tissue factor procoagulants in cancer cells
22. Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas
23. Patterns of fibrinolytic parameters in patients with gastrointestinal carcinomas
24. Location of plasminogen activator and PA inhibitor in human colorectal adenocarcinomas
25. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma
26. Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma
27. Which factors affect high D-dimer levels in the elderly?
28. Fibrin degeneration product concentrations (D-dimers) in the course of aging
29. Haemostatic risk factors for cardiovascular diseases
30. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study